Immuno-oncology congresses and symposia

Meet us at the booth or attend our symposia or product theaters

 

Miltenyi Biotec is actively involved in numerous congresses worldwide focusing on immuno-oncology. Meet us at the booth and attend our corporate symposia or product theaters to hear what we can offer for innovative research and cell therapy development. 

Check out the upcoming meetings below to find out where we will organize a corporate event or will have one of our scientists present within the regular sessions.

Upcoming meetings with a focus on immuno-oncology:

AACR Annual Meeting 2019
March 29–April 03, 2019 | Atlanta GA, USA

Miltenyi Biotec Spotlight Theater, Monday, April 01, 12:30 p.m. – 01:30 p.m.
“Understand nature’s complexity: Miltenyi Biotec’s new imaging platforms for high-content and 3D imaging”
 

103rd Annual Meeting of the American Association of Immunologists (AAI) 2019
May 09–13, 2019 | San Diego, USA


ISCT Annual Meeting 2019
May 29–June 1, 2019 | Melbourne, Australia

Miltenyi Biotec Corporate Symposium, Wednesday, May 29, 04:30–06:30 p.m.
“Technology driven progress in cellular therapy”

CliniMACS Prodigy® Workshops,  Thursday, May 30 & Friday, May 31, Room 206
Join our live demonstrations of the CliniMACS Prodigy. Learn how genetically modified T cells, or stem cells and their derivatives, can be manufactured in an automated, closed, and scalable system
 

Immuno-Oncology Summit
August 05-09, 2019 | Boston MA, USA

Training Seminar, Monday/Tuesday, August 05-06
“Introduction to Cancer Immunotherapy Discovery and Development”
Dina Schneider, Ph.D., Associate Director, Translational Research, Lentigen Technology, a Miltenyi Biotec Company
 

15th International Symposium on Dendritic Cells
June 10–14, 2018  | Aachen, Germany 

“Personalized dendritic cell vaccines for ovarian cancer patients”
Lunch Symposium, Lana Kandalaft 
Monday, June 11

Immuno-Oncology Summit
August 27–31, 2018 | Boston, USA

“Automation and decentralization of CAR T cell manufacture”
Boro Dropulic, Ph.D., CSO & General Manager, Lentigen Technology, Inc.
Tuesday, August 28, 03:00 p.m. (Find the program here)

“Automation meets cell separation: primary cells for immuno-oncology assays”
Lotta Räty, Product Manager, Cell Separation, Miltenyi Biotec
Wednesday, August 29, 09:30 a.m. (Find the program here)

ECI 2018 – 5th European Congress of Immunology
September 02–05, 2018 | Amsterdam, Netherlands

CAR-TCR Summit
September 04–07, 2018 | Boston, USA

Cell & Gene Therapy Europe
September 11–12, 2018 | London, UK

ELRIG Drug Discovery 2018 
October 09–10, 2018 | London, UK

“Automation meets cell separation: primary cells for immuno-oncology assays”
Lotta Räty, Product Manager, Cell Separation, Miltenyi Biotec, Germany
Wednesday, October 10, 12:00–12:30 p.m., Platinum Suite 2

The 9th Asian Cellular Therapy Organization Meeting (ACTO 2018)
October 26–28, 2018 | Chiang Mai, Thailand  

Miltenyi Biotec Dinner Symposium “Emerging technologies and clinical advancements in cell therapy”
Friday, October 26, 06:00–07:15 p.m.
Moderator: Yingzi Ge, Miltenyi Biotec, Germany
Presentations:
“Automated manufacturing of chimeric antigen receptor T cells”
Lin Yang, Ph.D., CSO PersonGen BioTherapeutics, China

“CliniMACS Prodigy® Adherent Cell Culture System – An automated, closed, and GMP-compliant platform for complex human cell manufacturing”
Chao Sheng, Ph.D., Product Manager, Regenerative Medicine, Miltenyi Biotec, Germany 

60th ASH Annual Meeting & Exposition
December 01–04, 2018 | San Diego, USA

TCT | Transplantation and Cellular Therapy Meetings
(formerly BMT Tandem Meetings)
February 20–24, 2019 | Houston TX, USA

Miltenyi Biotec Product Theater, Friday, February 22, 01:30–02:30 p.m.
“The Latest Advances in Cell Therapy Technologies”
 

CAR-TCR Summit Europe
February 25–27, 2019 | London, UK

“The Future of CAR-T Cell Manufacturing”
Michael Papadimitrios, Product Manager, Miltenyi Biotec
Tuesday, February 26, 12:45 p.m.
 

Cell Therapy Manufacturing Asia
February 26–March 01, 2019 | Tokyo, Japan

“T-cell engineering: Driving automation towards commercialization”
Silvio Weber, R&D Industry Business, Miltenyi Biotec
Wednesday, February 27, 12:15 p.m.

3rd Annual Next Gen Immuno-Oncology Congress
March 14–15, 2019 | London, UK

"Validation methods and innovative tools in IO discovery"
Emiliano Melandri, Product Manager, Miltenyi Biotec 
Thursday, March 14, 10:05 a.m.
 

Cellular Therapy 2019
March 22–23, 2019 | Erlangen, Germany
 

45th Annual Meeting of the European Society for Blood and Marrow Transplantation
March 24–27, 2019 | Frankfurt, Germany

Miltenyi Biotec Industry Symposium, Sunday, March 24, 12:30–02:00 p.m.
“Exploit the benefits of cell therapy”

Kiadis and Miltenyi Biotec Joint Industry Symposium, Sunday, March 24, 04:30–06:00 p.m.
“Innovations in ex vivo T-cell depletion

Immuno-oncology supported by Miltenyi Biotec

From basic research to innovative therapies

Click here to find our various immuno-oncology activities: Benefit from our experience, meet the experts, or share your research story.
Immuno-oncology